Drug Type Small molecule drug |
Synonyms BPRX 060216, BPRX060216 |
Target |
Mechanism CB agonists(Cannabinoid receptor agonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Eosinophilic Esophagitis | Preclinical | US | 28 Dec 2016 |